They also contribute to substantial weight loss for people with obesity and show promise in helping to manage other conditions, such as cardiovascular disease and substance use disorder
To address this need, we conducted a systematic review and meta-analysis to evaluate and compare the efficacy of GLP-1 RAs in promoting weight loss and modulating body composition in individuals with overweight or obesity with or without T2DM
Science Spyglass GLP-1 receptor assay: drug discovery in the metabolic disorders field Metabolic disorders , particularly type 2 diabetes and obesity , represent a major global health burden
In a study led by Marathe et al., retatrutide-induced weight loss reduced tumor engraftment, delayed tumor onset, and significantly attenuated tumor growth in pancreatic and lung cancer models, with greater tumor suppression than the GLP-1 receptor agonist semaglutide
The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1
However, these ingredients are not tested as transdermal patches and further research is needed in this regard